These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1921261)

  • 1. RAS gene mutations in multiple myeloma and related monoclonal gammopathies.
    Matozaki S; Nakagawa T; Nakao Y; Fujita T
    Kobe J Med Sci; 1991 Feb; 37(1):35-45. PubMed ID: 1921261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies.
    Martín P; Santón A; García-Cosío M; Bellas C
    Int J Oncol; 2005 Oct; 27(4):1023-8. PubMed ID: 16142319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenes in multiple myeloma: point mutation of N-ras.
    Paquette RL; Berenson J; Lichtenstein A; McCormick F; Koeffler HP
    Oncogene; 1990 Nov; 5(11):1659-63. PubMed ID: 2267133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high frequency of N-RAS oncogene mutations in multiple myeloma.
    Tanaka K; Takechi M; Asaoku H; Dohy H; Kamada N
    Int J Hematol; 1992 Oct; 56(2):119-27. PubMed ID: 1421173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and RAS gene mutations in multiple myeloma.
    Portier M; Molès JP; Mazars GR; Jeanteur P; Bataille R; Klein B; Theillet C
    Oncogene; 1992 Dec; 7(12):2539-43. PubMed ID: 1461658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis.
    Bezieau S; Devilder MC; Avet-Loiseau H; Mellerin MP; Puthier D; Pennarun E; Rapp MJ; Harousseau JL; Moisan JP; Bataille R
    Hum Mutat; 2001 Sep; 18(3):212-24. PubMed ID: 11524732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias.
    Corradini P; Inghirami G; Astolfi M; Ladetto M; Voena C; Ballerini P; Gu W; Nilsson K; Knowles DM; Boccadoro M
    Leukemia; 1994 May; 8(5):758-67. PubMed ID: 8182933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N- and K-ras oncogenes in plasma cell dyscrasias.
    Corradini P; Ladetto M; Inghirami G; Boccadoro M; Pileri A
    Leuk Lymphoma; 1994 Sep; 15(1-2):17-20. PubMed ID: 7858496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction.
    Stratton MR; Fisher C; Gusterson BA; Cooper CS
    Cancer Res; 1989 Nov; 49(22):6324-7. PubMed ID: 2680062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias.
    Corradini P; Ladetto M; Voena C; Palumbo A; Inghirami G; Knowles DM; Boccadoro M; Pileri A
    Blood; 1993 May; 81(10):2708-13. PubMed ID: 8490179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of ras gene mutations in acute myeloid leukemia by the polymerase chain reaction and oligonucleotide probes.
    Chin YM; Bosco JJ; Koh CL
    Singapore Med J; 1992 Feb; 33(1):48-50. PubMed ID: 1598607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
    Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
    Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
    Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
    Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies.
    Seidl S; Ackermann J; Kaufmann H; Keck A; Nösslinger T; Zielinski CC; Drach J; Zöchbauer-Müller S
    Cancer; 2004 Jun; 100(12):2598-606. PubMed ID: 15197802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.